Overall survival (OS) data, published simultaneously by the Journal of Clinical Oncology, 2 show the longest survival data ...

Recent headlines proclaim a ‘potential’ or ‘functional’ cure for multiple myeloma, but the fight against the disease must ...

After a chaotic year that has seen the attrition of over half the FDA’s senior leadership, many of these individuals have ...

Keytruda plus Lenvima demonstrates durable 5-year survival benefit versus chemotherapy for patients with advanced endometrial carcinoma following one prior platinum-based regimen ...